FDA-2024-0041-V441
Major variation for application FDA-2024-0041. Major variation: Facility Change for Lorlatenilib — critical change
Variation Number
FDA-2024-0041-V441
Type
Major
Application
Change
Status
Active
Fee
€50,076
Submitted
—
Approved
—
Description
Major variation: Facility Change for Lorlatenilib — critical change